These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 20585396)
21. Endogenous dendritic cells are required for amplification of T cell responses induced by dendritic cell vaccines in vivo. Kleindienst P; Brocker T J Immunol; 2003 Mar; 170(6):2817-23. PubMed ID: 12626531 [TBL] [Abstract][Full Text] [Related]
22. B lymphocytes as direct antigen-presenting cells for anti-tumor DNA vaccines. Colluru VT; McNeel DG Oncotarget; 2016 Oct; 7(42):67901-67918. PubMed ID: 27661128 [TBL] [Abstract][Full Text] [Related]
23. The siRNA cocktail targeting interleukin 10 receptor and transforming growth factor-β receptor on dendritic cells potentiates tumour antigen-specific CD8(+) T cell immunity. Ahn YH; Hong SO; Kim JH; Noh KH; Song KH; Lee YH; Jeon JH; Kim DW; Seo JH; Kim TW Clin Exp Immunol; 2015 Jul; 181(1):164-78. PubMed ID: 25753156 [TBL] [Abstract][Full Text] [Related]
24. Targeting dendritic cells in humanized mice receiving adoptive T cells via monoclonal antibodies fused to Flu epitopes. Graham JP; Authie P; Yu CI; Zurawski SM; Li XH; Marches F; Flamar AL; Acharya A; Banchereau J; Palucka AK Vaccine; 2016 Sep; 34(41):4857-4865. PubMed ID: 27595442 [TBL] [Abstract][Full Text] [Related]
25. Effective Priming of Herpes Simplex Virus-Specific CD8 Whitney PG; Makhlouf C; MacLeod B; Ma JZ; Gressier E; Greyer M; Hochheiser K; Bachem A; Zaid A; Voehringer D; Heath WR; Wagle MV; Parish I; Russell TA; Smith SA; Tscharke DC; Gebhardt T; Bedoui S J Virol; 2018 Feb; 92(3):. PubMed ID: 29142130 [TBL] [Abstract][Full Text] [Related]
26. Dendritic cell immunotherapy. Sabado RL; Bhardwaj N Ann N Y Acad Sci; 2013 May; 1284():31-45. PubMed ID: 23651191 [TBL] [Abstract][Full Text] [Related]
27. Unique functions of splenic CD8alpha+ dendritic cells during infection with intracellular pathogens. Neuenhahn M; Busch DH Immunol Lett; 2007 Dec; 114(2):66-72. PubMed ID: 17964665 [TBL] [Abstract][Full Text] [Related]
28. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells. Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200 [TBL] [Abstract][Full Text] [Related]
29. Dendritic cell preactivation impairs MHC class II presentation of vaccines and endogenous viral antigens. Young LJ; Wilson NS; Schnorrer P; Mount A; Lundie RJ; La Gruta NL; Crabb BS; Belz GT; Heath WR; Villadangos JA Proc Natl Acad Sci U S A; 2007 Nov; 104(45):17753-8. PubMed ID: 17978177 [TBL] [Abstract][Full Text] [Related]
32. Costimulatory ligand CD70 allows induction of CD8+ T-cell immunity by immature dendritic cells in a vaccination setting. Keller AM; Xiao Y; Peperzak V; Naik SH; Borst J Blood; 2009 May; 113(21):5167-75. PubMed ID: 19279334 [TBL] [Abstract][Full Text] [Related]
33. Spreading the load: Antigen transfer between migratory and lymph node-resident dendritic cells promotes T-cell priming. Mueller SN Eur J Immunol; 2017 Oct; 47(10):1798-1801. PubMed ID: 28845904 [TBL] [Abstract][Full Text] [Related]
34. The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: relation to central nervous system antitumor immunity. Prins RM; Craft N; Bruhn KW; Khan-Farooqi H; Koya RC; Stripecke R; Miller JF; Liau LM J Immunol; 2006 Jan; 176(1):157-64. PubMed ID: 16365406 [TBL] [Abstract][Full Text] [Related]
35. A Highly Active Form of XCL1/Lymphotactin Functions as an Effective Adjuvant to Recruit Cross-Presenting Dendritic Cells for Induction of Effector and Memory CD8 Matsuo K; Kitahata K; Kawabata F; Kamei M; Hara Y; Takamura S; Oiso N; Kawada A; Yoshie O; Nakayama T Front Immunol; 2018; 9():2775. PubMed ID: 30542351 [TBL] [Abstract][Full Text] [Related]
36. Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses. Silva M; Silva Z; Marques G; Ferro T; Gonçalves M; Monteiro M; van Vliet SJ; Mohr E; Lino AC; Fernandes AR; Lima FA; van Kooyk Y; Matos T; Tadokoro CE; Videira PA Oncotarget; 2016 Jul; 7(27):41053-41066. PubMed ID: 27203391 [TBL] [Abstract][Full Text] [Related]
37. Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR. Klechevsky E; Flamar AL; Cao Y; Blanck JP; Liu M; O'Bar A; Agouna-Deciat O; Klucar P; Thompson-Snipes L; Zurawski S; Reiter Y; Palucka AK; Zurawski G; Banchereau J Blood; 2010 Sep; 116(10):1685-97. PubMed ID: 20530286 [TBL] [Abstract][Full Text] [Related]
38. Tissue localization of tumor antigen-loaded mouse dendritic cells applied as an anti-tumor vaccine and their influence on immune response. Rossowska J; Pajtasz-Piasecka E; Szyda A; Zietara N; Duś D Folia Histochem Cytobiol; 2007; 45(4):349-55. PubMed ID: 18165174 [TBL] [Abstract][Full Text] [Related]
39. β-Catenin in dendritic cells exerts opposite functions in cross-priming and maintenance of CD8+ T cells through regulation of IL-10. Fu C; Liang X; Cui W; Ober-Blöbaum JL; Vazzana J; Shrikant PA; Lee KP; Clausen BE; Mellman I; Jiang A Proc Natl Acad Sci U S A; 2015 Mar; 112(9):2823-8. PubMed ID: 25730849 [TBL] [Abstract][Full Text] [Related]
40. Plasmacytoid dendritic cells cross-prime naive CD8 T cells by transferring antigen to conventional dendritic cells through exosomes. Fu C; Peng P; Loschko J; Feng L; Pham P; Cui W; Lee KP; Krug AB; Jiang A Proc Natl Acad Sci U S A; 2020 Sep; 117(38):23730-23741. PubMed ID: 32879009 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]